Blog
Acting with integrity within the sometimes-unethical pharmaceutical industry
Book: Bottle of Lies: The Inside Story of the Generic Drug Boom, by Katherine Eban Good read. I honestly forgot about the phone call I had with Katherine Eban more than 5 years ago, so it took me by surprise to see my name in her book. Yes, right there on page 224 in...
ICH releases updated draft guideline for general considerations for clinical studies
The International Council for Harmonization (ICH) released an updated version of its guideline on general considerations for clinical trials, RAPS reports. ICH released the guideline, E8(R1), earlier this May for public consultation on the draft.The...
Meet Pearl IRB at ACRP 2019 in Nashville, TN
Pearl IRB will attend and exhibit at the upcoming Association of Clinical Research Professionals (ACRP) 2019 conference. The event takes place April 12 - 15 in Nashville, Tennessee. Stop by our booth (#549) to meet our team! About ACRP 2019 ACRP 2019 brings the...
Adoption of eConsent: When will it begin?
Rapid development of technology in the medical industry is forcing life science companies and research institutions to review and modify internal procedures to adapt. Electronic informed consent (eConsent), though still highly debated, is a prominent example of a...
Principle Investigators often struggle to follow their own protocol, FDA records reveal
According to recent records published by the U.S. Food and Drug Administration (FDA), the medical industry is experiencing an alarming rise in the number of failures to follow protocol. A report produced by FDA’s Bioresearch...